Anavex Life Sciences (AVXL) Tops Q2 EPS by 2c

Anavex Life Sciences (NASDAQ: AVXL) reported Q2 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Anavex Life Sciences (AVXL) click here.

You May Also Be Interested In

• Corporación América Airports S.A. (CAAP) Misses Q2 EPS by 18c
• UBS Upgrades Kingspan Group PLC (KSP:ID) to Buy
• Taylor Devices (TAYD) Misses Q4 EPS by 31c